What is in the pipeline for Biogen?
Biogen will present an overview of its Alzheimer’s disease pipeline with the recent FDA-approved ADUHELM serving as the foundation of a multi-target, multi-modality Alzheimer’s disease franchise.
What is the Alzheimer’s drug from Biogen?
Biogen will replace its CEO and significantly cut its sales staff in response to disappointments for its Alzheimer’s disease treatment aducanumab. The US Food and Drug Administration approved aducanumab, sold under the brand name Aduhelm, in a controversial decision last June.
How does Biogen aducanumab work?
Since aducanumab works by helping the immune system remove amyloid deposits from the brain, some patients may experience an exaggerated immune response in the brain. If this occurs, it may cause blood vessel leakiness leading to localized brain swelling, small spots of bleeding in the brain, or both.
What MS drug does Biogen make?
With its high kinase selectivity and high penetrance of the central nervous system, orelabrutinib has the potential to be a best-in-class BTK inhibitor for relapsing forms of MS and progressive forms of MS, as well as complementing our existing portfolio. Learn more about the orelabrutinib clinical trial.
What is the newest drug for dementia?
Aduhelm is the first drug on the market able to remove amyloid, the sticky substance that builds up in the brains of Alzheimer’s patients. It’s also the first new Alzheimer’s drug approved since 2003.
What does Biogen Idec do?
Biogen Idec was created in 2003 through the merger of Biogen and IDEC Pharmaceuticals, creating one of the world’s leading research-based life sciences organizations. The company has since focused its research and commercial efforts in three core areas: neurology, immunology and hematology.
What company makes Ocrevus?
Genentech: Ocrevus® (ocrelizumab)
What happened to Biogen Idec?
CAMBRIDGE, Mass. –(BUSINESS WIRE)–Effective today, Biogen Idec is known simply as Biogen (NASDAQ: BIIB).
Who is Biogen Idec?
Through cutting-edge science and medicine, Biogen Idec discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hemophilia and autoimmune disorders. Founded in 1978, Biogen Idec is the world’s oldest independent biotechnology company.
What does the Biogen Foundation do?
The Biogen Foundation supports access to science education and to essential human services for children and their families in the communities in which Biogen facilities are located.
What is the Biogen Foundation doing to help victims of covid-19?
The Biogen Foundation has committed $10M to aid in COVID-19 relief efforts around the world. At this time, the Biogen Foundation’s COVID-19 relief efforts are focused on the following categories:
What is the Biogen employee matching Gifts Program?
U.S. Employee Matching Gifts Program matches Biogen employee gifts to non-profit organizations — maximizing community benefit and demonstrating the powerful difference we can collectively make in the lives of others. The Foundation matches Biogen employee donations to eligible organizations dollar-for-dollar, up to $25,000 per employee, per year.